GEWEBESELEKTIVE TRANSGENEXPRESSION

European patent · EP3374510 · In force

Register entry

Publication number
EP3374510
Application number
EP16797497
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 10, 2016
Published
Sep 19, 2018
Granted
Jun 21, 2023
Protection ends at the latest
Nov 9, 2036
Next annual fee due
Nov 30, 2026
IPC classes
C12N 15/85 (2006.01)
Priority
EP 15194155 11.11.2015
EP 16169261 11.05.2016
PCT application
PCT/EP2016/077351 10.11.2016
PCT publication
WO2017/081204 18.05.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  5. Jul 12, 2023

    Owner

    Owner
    Genome Biologics UG, Lange Strasse 59, 60311 Frankfurt am Main, Germany → Genome Biologics GmbH, Danziger Weg 17, 61476 Kronberg im Taunus, Germany

    Published in Swissreg on 12.07.2023

  6. Jun 21, 2023

    Granted

    Published in Swissreg on 21.06.2023

Parties

Holder

Genome Biologics GmbH

Danziger Weg 17, 61476 Kronberg im Taunus, DE

Inventor

KRISHNAN, Jaya

60323 Frankfurt am Main, DE

WARD, Jonathan

8620 Wetzikon

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.